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The mechano-enzyme dynamin-related protein 1 plays an important role in
mitochondrial fission and is implicated in cell physiology. Dysregulation of Drp1
is associated with abnormal mitochondrial dynamics and neuronal damage.
Drp1 shares structural and functional similarities with dynamin 1 with respect
to domain organization, ability to self-assemble into spiral-like oligomers and
GTP-cycle-dependent membrane scission. Structural studies of human
dynamin-1 have greatly improved the understanding of this prototypical
member of the dynamin superfamily. However, high-resolution structural
information for full-length human Drp1 covering the GTPase domain, the
middle domain and the GTPase effector domain (GED) is still lacking. In order
to obtain mechanistic insights into the catalytic activity, a nucleotide-free
GTPase-GED fusion protein of human Drp1 was expressed, purified and
crystallized. Initial X-ray diffraction experiments yielded data to 2.67 Å
resolution. The hexagonal-shaped crystals belonged to space group P21212,
with unit-cell parameters a = 53.59, b = 151.65, c = 43.53 Å, one molecule per
asymmetric unit and a solvent content of 42%. Expression of selenomethionine-
labelled protein is currently in progress. Here, the expression, purification,
crystallization and X-ray diffraction analysis of the Drp1 GTPase-GED fusion
protein are presented, which form a basis for more detailed structural and
biophysical analysis.
1. Introduction
Mitochondria play a critical role in diverse biological processes such
as ATP synthesis, calcium homeostasis and apoptosis (Wallace & Fan,
2010). These highly dynamic organelles undergo frequent fusion and
fission to regulate their number, morphology, distribution and func-
tion (Bereiter-Hahn & Vöth, 1994; Youle, 2005; Chen & Chan, 2009).
The dynamin-related proteins (DRPs) are responsible for main-
taining this fusion–fission equilibrium. They represent a subfamily of
the dynamin superfamily, a group of highly conserved large GTPases
which are known for their ability to self-assemble into high-order
ring-like or spiral-like oligomers and to display oligomerization-
dependent GTPase activity (Praefcke & McMahon, 2004; Lackner et
al., 2009). Despite these common biochemical features, DRPs contain
only three of the five domains typically found in the classical
dynamins, e.g. dynamin-1: an N-terminal GTPase domain, a middle
domain (MID) and a C-terminal GTPase effector domain (GED).
Whereas the GTPase domain shows a high degree of sequence
conservation throughout the superfamily, the MID and GED are
more variable. Interestingly, the MID, together with intramolecular
and intermolecular interactions formed by the GED, plays important
roles during self-assembly (Hoppins et al., 2007).
Dynamin-related protein 1 (Drp1), a key regulator of mitochon-
drial fission, has an additional unstructured region between the MID
and GED. This so-called insert B or variable domain (VD) has been
suggested to play an important role in Drp1 regulation and self-
assembly (Heymann & Hinshaw, 2009; Strack & Cribbs, 2012; Fig. 1a).
Drp1 is evolutionarily conserved throughout most kingdoms of life,
indicating its fundamental importance to cell biology (Westermann,
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2010; Reddy et al., 2011). In vivo studies with drp1 knockout mice or
mice carrying drp1 mutations confirmed its essential role in cell
survival (Wakabayashi et al., 2009; Waterham et al., 2007; Ishihara et
al., 2009). In humans, at least six different Drp1 isoforms are known,
which are expressed in a tissue-specific and cell-type-specific manner
(Reddy et al., 2011; Ishihara et al., 2009; Chang & Blackstone, 2010).
In vivo and in vitro studies showed that Drp1 exists in a dimer–
tetramer equilibrium in the cytoplasm (Shin et al., 1999; Zhu et al.,
2004; Chang et al., 2010; Bossy et al., 2010). As a response to cellular
stimuli, Drp1 is recruited to the mitochondrial outer membrane,
where it self-assembles into spiral-like higher oligomeric structures at
mitochondrial fission sites. These Drp1 clusters can be visualized as
ribbons surrounding mitochondria or foci (Zhu et al., 2004; Chang
et al., 2010; Frank et al., 2001). Negative-stain electron microscopy
revealed that Drp1 self-assembles into large spiral-shaped oligomers
in the presence of GTP or nonhydrolysable GTP in vitro (Smirnova et
al., 2001; Song et al., 2011; Yoon et al., 2001). Studies using liposomes,
which mimic the mitochondrial outer membrane, revealed Drp1
aggregation at membrane liposomes concurrent with membrane
deformation (Yoon et al., 2001). This finding suggests the involvement
of Drp1 in membrane remodelling and scission. However, in vitro
studies using Drp1 mutants and GTP analogues showed that GTP
binding, but not GTP hydrolysis, is essential for oligomer assembly
(Yoon et al., 2001; Smirnova et al., 2001). Indeed, it has been reported
for the yeast homologue Dnm1 that the GTPase activity increases
after assembly on liposomes followed by disassembly of the high-
order oligomers (Ingerman et al., 2005; Mears et al., 2011; Mears &
Hinshaw, 2008). Thus, GTP hydrolysis might induce a conformational
change providing the mechanochemical work necessary for the
mitochondrial fission process (Knott & Bossy-Wetzel, 2008; Otera &
Mihara, 2011; Mears et al., 2011).
Several factors that are required for membrane binding and
regulation of Drp1 during this dynamic mechanism have already been
identified (Dikov & Reichert, 2011; Otera et al., 2010; Palmer et al.,
2011; Zhao et al., 2011). Recent evidence also suggests that diverse
post-translational modifications of Drp1 regulate mitochondrial
fission (Chang & Blackstone, 2010; Oettinghaus et al., 2012; Otera &
Mihara, 2012; Elgass et al., 2012; Chang et al., 2010). However, their
effects on Drp1 activity are incompletely understood and are a matter
of current debate (Cho et al., 2009; Bossy et al., 2010; Chang &
Blackstone, 2010).
Unravelling the molecular mechanism of human Drp1-mediated
mitochondrial fission will allow us to modulate Drp1 activity in the
pathogenesis of disease (Song et al., 2011). For example, recent
studies have revealed that excessive mitochondrial fission in degen-
erative diseases is caused by increased Drp1 activity (Knott et al.,
2008; Elgass et al., 2012; Manczak & Reddy, 2012).
High-resolution structural data for the human Drp1 GTPase
domain will provide us with important insights into the mechanistic
similarities and differences compared with dynamin-1. Construct
design for the Drp1 GTPase domain was carried out on the basis of
previously described GTPase-GED fusion protein structures of other
dynamin superfamily members, such as human dynamin-1 (Chappie
et al., 2010) and a plant Drp1 homologue (Chen et al., 2012). The
Drp1 GG fusion protein shares 48 and 41% sequence identity with
the GTPase-GED fusion proteins of human dynamin-1 (PDB entries
2x2e and 3zyc; Chappie et al., 2010, 2011) and Arabidopsis thaliana
Drp1A (AtDrp1A; PDB entries 3t34 and 3t35; Yan et al., 2011),
respectively. Here, we report the expression, purification, crystal-
lization and X-ray crystallographic characterization of a native fusion
protein containing the GTPase domain and the C-terminal part of the
GED of human Drp1.
2. Experimental methods
2.1. Cloning
To produce a stable and homogenous but still functional protein
for crystallization experiments, the GTPase domain of human Drp1
(amino acids 1–327) was fused to the C-terminal part of the GED
(amino acids 711–736) by a (GS)4 linker (Fig. 1b). By removing the
MID and the unstructured insert B the formation of higher-order
oligomers was prevented and protein stability was increased. To
generate the Drp1 GTPase-GED (GG) fusion construct the following
four primers were designed: 50-CTGGTCATATGGAGGCGCTA-
ATTCCTGTC-30 containing an NdeI restriction site, 50-CTGGT-
CTCGAGCCAAAGATGAGTCTCCCG-30 containing an XhoI
restriction site, 50-GGTGAACCCGTGGATGGATCAGGATCAG-
GATCAGGATCA-30 and 50-ATCAGCTGCTTCTTTTGATCCTG-
ATCCTGATCCTGATCC-30. The K38A mutation was introduced by
overlap PCR using the mutagenic primers 50-GAACGCAGAGC-
AGCGGAGCAAGCTCAGTGCTAGAAAG-30 and 50-CTTTCTA-
GCACTGAGCTTGCTCCGCTGCTCTGCGTTC-30. Drp1 fragments
were PCR-amplified from template DNA containing full-length Drp1
isoform 2 in pET21 (GenBank Accession No. NM_012063.2) using
iProof High-Fidelity DNA Polymerase (Bio-Rad). The PCR product
was digested with NdeI and XhoI and cloned into pET21 (Novagen),
resulting in the attachment of two non-native amino acids (leucine
and glutamic acid) and a His6 tag at the C-terminus of the protein.
The sequence was verified by DNA sequencing (Eurofins MWG
Operon).
2.2. Expression
For protein expression, the Drp1 GG fusion construct and a
construct containing a K38A substitution mutation in the GTPase
domain rendering the Drp1 enzymatically inactive were transformed
into Escherichia coli BL21 (DE3) Star cells and grown on LB plates
containing 50 mg ml1 ampicillin (Carl Roth) overnight at 310 K.
Subsequently, cells were transferred into two Erlenmeyer flasks
containing 600 ml LB medium with 50 mg ml1 ampicillin and grown
at 310 K with agitation at 230 rev min1 until an OD600 of 0.8 was
attained. After induction with 0.5 mM isopropyl -thiogalactopyr-
anoside (Carl Roth), expression was performed overnight at 298 K.
The cells were harvested by centrifugation at 4500g for 20 min at
277 K. The cell pellets were dissolved in a 1/20 volume of lysis buffer
[50 mM KH2PO4 pH 7.8, 300 mM NaCl, 10%(v/v) glycerol, 5 mM
imidazole, 0.1 mg ml1 lysozyme] and frozen at 253 K overnight
before purification.
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Figure 1
Construct design and schematic representation of the Drp1 GG fusion protein. (a)
Full-length Drp1 consists of an N-terminal GTPase domain (green) and a helical
middle domain (blue) followed by an unstructured region (insert B or variable
domain) and a C-terminal GED (pink). (b) The GG fusion protein consists of the
complete GTPase domain (amino acids 1–327) fused to a C-terminal fragment of
the GED (amino acids 711–736) via a (GS)4 linker.
2.3. Protein purification
After thawing, the cells were lysed on ice by two cycles of soni-
cation (Bandelin Electronic UW2070) at 70% of the maximum
intensity amplitude for 3 min. DNA digestion was performed with
10 mg ml1 DNase I (Fermentas) for 30 min at 293 K. The cell lysates
were cleared by centrifugation at 18 000g for 20 min at 277 K. The
supernatant was loaded onto Ni–NTA resin (GE Healthcare) pre-
equilibrated in wash buffer [20 mM Tris pH 7.8, 300 mM NaCl,
40 mM imidazole, 10%(v/v) glycerol, 10%(w/v) sucrose]. To remove
impurities, the nickel beads were washed with 30 column volumes of
wash buffer. The protein was eluted with at least two column volumes
of elution buffer [20 mM Tris pH 7.8, 300 mM NaCl, 10%(v/v)
glycerol, 500 mM imidazole] and further purified on an ÄKTA FPLC
system using a Superdex 75 10/300 GL column (GE Healthcare) pre-
equilibrated with gel-filtration buffer (30 mM Tris pH 7.8, 100 mM
NaCl, 2 mM DTT, 1 mM EDTA). The Drp1 GG fusion protein eluted
as a monomer at a retention volume of approximately 11 ml (Fig. 2a)
and displayed virtually no impurities (Fig. 2b). Amicon Ultra
centrifugal filter units (10 kDa cutoff, Millipore) were used to
concentrate the protein to 10 mg ml1 and it was stored at 193 K. The
protein concentration was determined by UV absorbance at 280 nm.
Peptide mass fingerprinting (Toplab, Munich, Germany) unambigu-
ously identified the native protein as the Drp1 GG fusion protein.
Furthermore, the intact mass of 40.923 kDa determined by mass
spectrometry (Toplab, Munich, Germany) corresponded well to the
calculated mass of 40.956 kDa. Drp1 full-length isoform 2 was
expressed and purified as described elsewhere (Song et al., 2011).
2.4. Drp1 GG fusion protein shows GTPase activity
The Drp1 GG fusion protein was tested for GTPase activity using
the continuous regenerative coupled GTPase assay (Ingerman &
Nunnari, 2005; Fig. 3). The protein was equilibrated in a buffer
consisting of 25 mM HEPES/PIPES pH 7.0, 150 mM NaCl and was
diluted to a concentration of 0.1 mg ml1. The absorbance (340 nm)
correlating with NADH depletion at increasing GTP concentrations
(0, 10, 20, 30, 50, 100, 250, 500 and 1000 mM) was measured at 303 K
for 85 min with 32 s per cycle using an Infinite M200 plate reader
(Tecan). Drp1 full-length isoform 2 and the enzymatically inactive
K38A GG fusion protein (Smirnova et al., 1998) were used as positive
and negative controls, respectively.
2.5. Protein crystallization
Crystallization of the Drp1 GG fusion protein (10 mg ml1) was
performed in gel-filtration buffer using the sitting-drop vapour-
diffusion method at 293 K. Commercial sparse-matrix screens such as
Index (Hampton Research) and JCSG-plus (Molecular Dimensions)
were used to screen for initial crystal hits. Drops were prepared by
mixing 0.4 ml reservoir solution with 0.4 ml protein solution using a
Hydra II Plus One (Matrix Ltd) liquid-handling system and were
equilibrated against 50 ml reservoir solution in 96-well sitting-drop
plates (Greiner). Stacks of thin crystal plates (Fig. 4a) were observed
within 9 d in condition A [0.2 M lithium sulfate, 0.1 M bis-Tris pH 5.5,
25%(v/v) PEG 3350]. Furthermore, initial crystals in the form of
clusters of needles were found in condition B (0.1 M sodium citrate
pH 5.5, 20% PEG 3000).
Initial hits were refined manually by varying the buffer pH, the
precipitant concentration or the protein concentration in 96-well
plates. The crystals found in condition A were not reproducible,
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Figure 2
Purification of the Drp1 GG fusion protein. (a) Size-exclusion analysis. After Ni–
NTA purification, proteins were loaded onto a Superdex 75 gel-filtration column
and fractions containing protein were collected. In the absence of nucleotides, the
protein eluted as a monomer at a retention volume of approximately 11 ml, which
corresponds to a molecular mass of approximately 40 kDa. The retention volumes
of molecular-mass standards (GE Healthcare) are displayed at the top. (b) SDS–
PAGE analysis. Protein fractions were loaded onto a 15% SDS–PAGE gel and
visualized by Coomassie Brilliant Blue staining. Lane E, eluted protein; lane M,
protein molecular-mass markers (labelled in kDa on the left). The retention
volumes are indicated at the top.
Figure 3
The Drp1 GG fusion protein displays GTPase activity: steady-state GTPase
activities of Drp1 GG fusion protein (native Drp1 GG fusion protein) in
comparison to Drp1 full-length isoform 2 and enzymatically inactive K38A mutant
(Drp1 GG fusion protein K38A). Data are the mean  standard deviation from
three independent measurements.
whereas a refined condition B (0.1 M sodium citrate pH 5, 27.5%
PEG 3000) with a protein concentration of 1.2 mg ml1, a drop size
of 0.8 ml and a 1:1 protein:reservoir solution ratio resulted in thin
hexagonal-shaped crystals (Fig. 4b).
2.6. Data collection and processing
Refined crystals obtained using condition B were flash-cooled in
liquid nitrogen without the addition of cryoprotectant. Diffraction
data were collected on BL14.1 operated by the Helmholtz-Zentrum
Berlin (HZB) at the BESSY II electron-storage ring (Berlin-
Adlershof, Germany; Mueller et al., 2012) at a wavelength of
0.91841 Å. A total of 180 diffraction images (Fig. 5) with an oscilla-
tion range of 1.0 were recorded using a Rayonics MX225 3 3 CCD
detector at a distance of 236.4 mm.
All data were indexed, integrated, scaled and merged using XDS
(Kabsch, 2010) using the XDSAPP graphical user interface (Krug et
al., 2012). For further information regarding data-collection and
processing statistics, see Table 1.
3. Results and discussion
Structural information from other DRP-family members indicates
that the C-terminus of the GED is necessary in order to interact with
both the carboxy-terminus and the amino-terminus of the GTPase
domain and to stabilize the GTPase domain (Chappie et al., 2009).
Therefore, a Drp1 GG fusion protein was designed by fusing the
GTPase domain to the C-terminal part of the GED. The protein
was cloned, expressed in E. coli and purified using a two-step
crystallization communications
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Figure 4
Crystal forms of the Drp1 GG fusion protein. (a) In condition A only star-shaped intergrown crystals were present which could not be reproduced. (b) Reproducible crystals
from condition B were only about 50  40  10 mm in size.
Table 1
Data-collection and processing statistics.
Values in parentheses are for the highest resolution shell.
Crystallization condition 0.1 M sodium citrate pH 5.5,
20% PEG 3000 [condition B]
Unit-cell parameters (Å, ) a = 53.59, b = 151.65, c = 43.53,
 =  =  = 90.00
X-ray source BL14.1, HZB, Berlin
Detector Rayonics MX225 3  3 CCD
Space group P21212
Wavelength (Å) 0.91841
Crystal-to-detector distance (mm) 236.4
Exposure time per image (s) 15
’ () 1.0
No. of images 180
Resolution (Å) 43.76–2.67 (2.83–2.67)
Reflections observed 76144 (11938)
Unique reflections 10686 (1678)
Multiplicity 7.13 (7.11)
Completeness of data (%) 99.8 (99.6)
hI/(I)i 9.73 (2.16)
Rmerge† (%) 18.2 (93.6)
Rr.i.m.‡ (%) 19.6 (100.9)
Rp.i.m.§ (%) 7.3 (37.3)
Mosaicity () 0.35
Molecules per asymmetric unit 1
Solvent content (%) 42
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i IiðhklÞ (Weiss, 2001) calculated with the program
RMERGE available upon request from M. S. Weiss.
Figure 5
Diffraction image of the Drp1 GG fusion protein: a diffraction image of the crystals
produced in condition B collected on BL14.1 at BESSY II, Berlin, Germany.
procedure. A continuous coupled GTPase activity assay showed that
the human Drp1 GG fusion protein is an active enzyme. However,
the GG fusion protein showed reduced GTPase activity in compar-
ison to the full-length protein (Fig. 3). The observed difference in
GTPase activities might be attributed to the inability of the Drp1 GG
fusion protein to assemble into higher-order oligomers, preventing
it from reaching maximal GTPase activity. According to the recently
published GG fusion protein structures of human dynamin and
AtDrp1A (Chappie et al., 2010; Yan et al., 2011), we expect that the
Drp1 GG fusion protein is able to dimerize via the GTPase domains
but cannot form tetramers or GTPase-stimulating spiral-like struc-
tures.
Initial crystallization experiments were set up and after 9 d crystal
plates could be observed in condition A consisting of 0.2 M lithium
sulfate, 0.1 M bis-Tris pH 5.5, 25%(v/v) PEG 3350. Clusters of needles
could be obtained in condition B consisting of 0.1 M sodium citrate
pH 5.5, 20% PEG 3000 and gave three-dimensional hexagonal crys-
tals after manual refinement of the conditions.
Crystals grown in condition B showed diffraction to 2.67 Å reso-
lution and belonged to space group P21212, with unit-cell parameters
a = 53.59, b = 151.65, c = 43.53 Å. Calculation of the Matthews
coefficient revealed one molecule in the asymmetric unit with a
solvent content of 42% (Matthews, 1968). For additional information
on data collection and processing, see Table 1. As molecular
replacement using human dynamin GG fusion protein (PDB entry
2x2e) as the search model failed, expression of selenomethionine-
labelled protein has been initiated.
Data collection was performed at the Helmholtz-Zentrum Berlin
für Materialien und Energie Elektronenspeicherring BESSY II,
Berlin, Germany and was supported by European Community’s
Seventh Framework Program (FP7/2007-2013) under grant agree-
ment No. 226716. SP was supported by Erwin-Schrödinger Postdoc
Fellowships from the Austrian Science Fund (J3173-N17). We thank
the Austrian Science Fund (FWF W_01213) for financial support.
EBW was supported by NIH grant R01 NS055195. Furthermore we
would like to thank Christina Doppler for cloning the K38A mutant.
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